Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,397,754 papers from all fields of science
Search
Sign In
Create Free Account
Patient Reported Outcomes Version of CTCAE
Known as:
PRO-CTCAE
, Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE)
A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials.(PRO-CTCAE)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
None
Past Seven Days Feeling Nothing Could Cheer You Up Interfering with Usual or Daily Activities
Past Seven Days Frequency of Hiccups
Past Seven Days Frequency of Sad or Unhappy Feelings
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Paget's disease of scrotum and penis case report of a re‐irradiation and review of the literature
A. Piras
,
A. Sanfratello
,
+7 authors
A. Daidone
Dermatologic Therapy
2020
Corpus ID: 220061530
Extramammary Paget's disease (EMPD) is a rare cutaneous adenocarcinoma generally arising in the anogenital region. Surgery is…
Expand
2019
2019
Routine surveillance for symptomatic toxicities with real‐time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the…
H. Pappot
,
Christina W Baeksted
,
A. Knoop
,
S. Mitchell
,
Aase Nissen
,
C. Johansen
The Breast Journal
2019
Corpus ID: 73439282
The Patient‐Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO‐CTCAE) was developed by the National…
Expand
2017
2017
Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy
Konrad Mohnike
,
K. Neumann
,
+13 authors
Jens Ricke
Strahlentherapie und Onkologie (Print)
2017
Corpus ID: 28080312
PurposeTo assess the efficacy, safety, and outcome of image-guided high-dose-rate (HDR) brachytherapy in patients with adrenal…
Expand
2015
2015
A prospective phase II trail of de-intensified chemoradiotherapy for low-risk HPV-associated oropharyngeal squamous cell carcinoma.
B. Chera
,
R. Amdur
,
+13 authors
W. Mendenhall
2015
Corpus ID: 56769441
6004 Background: This is a prospective multi-institutional phase II study of a substantial decrease in chemoradiotherapy (CRT…
Expand
2015
2015
Adjuvante IMRT beim Endometriumkarzinom
R. Förster
,
K. Lindel
Strahlentherapie und Onkologie (Print)
2015
Corpus ID: 44734795
benutzen. Die Dosis des vaginalen und nodalen Planungszielvolumen betrug 45 Gy in 25 Fraktionen. Um die Compliance mit den…
Expand
Review
2014
Review
2014
Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: Evaluating patient acceptability.
C. Brown
,
A. Vennettilli
,
+13 authors
Geoffrey Liu
Journal of Clinical Oncology
2014
Corpus ID: 36781008
64 Background: In a busy DC setting, the efficiency of identifying important treatment toxicities is essential to quality care…
Expand
Review
2013
Review
2013
Development program for the Japanese version of the PRO-CTCAE
Takuhiro Yamaguchi
,
S. Iwase
,
+13 authors
E. Basch
2013
Corpus ID: 63910308
Background The US National Cancer Institute(NCI)-Common Terminology Criteria for Adverse Events(CTCAE)is a longstanding…
Expand
2012
2012
Traitement de rattrapage par pémétrexed pour les CBNPC : étude rétrospective d’implémentation
Christiane Jungels
,
T. Berghmans
,
A. Meert
,
J. Lafitte
,
A. Scherpereel
,
J. Sculier
2012
Corpus ID: 196385577
2012
2012
Adapting the PRO-CTCAE for Patient Reporting of Toxicity in Radiation Oncology
S. McCloskey
,
P. Kupelian
,
S. Asch
,
R. Hays
,
J. Malin
2012
Corpus ID: 73353381
2010
2010
Refinement of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) via cognitive interviewing.
J. Hay
,
T. Atkinson
,
+7 authors
E. Basch
2010
Corpus ID: 73976666
9060 Background: A patient-reported outcomes (PRO) version of the NCI's Common Terminology Criteria for Adverse Events (CTCAE…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE